NCT05864989 Non-Incised Papilla Flap in Deep Supraossous Defects
| NCT ID | NCT05864989 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ain Shams University |
| Condition | Periodontitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 16 participants |
| Start Date | 2023-04-01 |
| Primary Completion | 2024-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 16 participants in total. It began in 2023-04-01 with a primary completion date of 2024-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study was to assess the effectiveness of NIPSA in periodontal lesions with deep supra-alveolar defects, measuring the clinical efficacy of this flap. The non-incised papilla surgical approach (NIPSA) is a novel technique that accesses the periodontal defect from apical direction and was established with the aim of creating clinical advances compared with marginal access techniques. The defects with a supra-alveolar components are more frequent than intrabony defects, there is very little evidence about their treatment .
Eligibility Criteria
Inclusion Criteria: * diagnosis of periodontal disease (periodontitis stage III and IV, grade A \[12\]; * non-smokers and former smokers who quit smoking at least 1 year previously * previous treatment for periodontal disease using non-surgical periodontal treatment completion of step I and II of periodontal therapy * compliance with periodontal maintenance and oral hygiene (FMPS at baseline ≤ 30%) * active residual pockets (positive bleeding on probing; BoP) associated with intrabony defects that were not resolved with non-surgical treatment after 4-6 months of maintenance. * periodontal lesions with probing depth (PD) \> 6 mm and supraalveolar defect (pre-diagnosis clinically (periodontal probe) Exclusion Criteria: * systemic disease contraindicating periodontal surgery, * smokers, and * third molars or teeth with incorrect * endodontic or restorative treatment.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05864989 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, studying Periodontitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05864989 currently recruiting?
Yes, NCT05864989 is actively recruiting participants. Contact the research team at mahetabmohamed@dent.asu.edu.eg for enrollment information.
Where is the NCT05864989 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT05864989 clinical trial?
NCT05864989 is sponsored by Ain Shams University. The trial plans to enroll 16 participants.